| Bioactivity | Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis[1]. |
| Invitro | Birtamimab 可以中和循环中的可溶性淀粉样蛋白和沉积的不溶性淀粉样蛋白，从而促进淀粉样蛋白沉积物的吞噬清除[1]。 |
| Name | Birtamimab |
| CAS | 1608108-91-3 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. AGertz M, et, al. Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design. Journal home page for Blood. Volume 138, Supplement 1, 23 November 2021, Page 2754. |